[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Blood Glucose Device-Global Market Status and Trend Report 2013-2023

February 2018 | 157 pages | ID: B1F3E01549FEN
MIReports Co., Limited

US$ 2,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Blood Glucose Device-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Blood Glucose Device industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Blood Glucose Device 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Blood Glucose Device worldwide, with company and product introduction, position in the Blood Glucose Device market
Market status and development trend of Blood Glucose Device by types and applications
Cost and profit status of Blood Glucose Device, and marketing status
Market growth drivers and challenges

The report segments the global Blood Glucose Device market as:

Global Blood Glucose Device Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North America
Europe
China
Japan
Rest APAC
Latin America

Global Blood Glucose Device Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Blood Glucose Monitors
Glucose Monitoring Strips
Lancets

Global Blood Glucose Device Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Hospitals
Diagnostics
Home Settings
Others

Global Blood Glucose Device Market: Manufacturers Segment Analysis (Company and Product introduction, Blood Glucose Device Sales Volume, Revenue, Price and Gross Margin):

Abbott Laboratories (U.S.)
ARKRAY (Japan)
Dexcom (U.S.)
F.Hoffmann-La Roche Ltd (Switzerland)
Johnson & Johnson (U.S.)
Medtronic (U.S.)
Nipro Diagnostics (U.S.)
Terumo Medical Corporation (U.S.)

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

CHAPTER 1 OVERVIEW OF BLOOD GLUCOSE DEVICE

1.1 Definition of Blood Glucose Device in This Report
1.2 Commercial Types of Blood Glucose Device
  1.2.1 Blood Glucose Monitors
  1.2.2 Glucose Monitoring Strips
  1.2.3 Lancets
1.3 Downstream Application of Blood Glucose Device
  1.3.1 Hospitals
  1.3.2 Diagnostics
  1.3.3 Home Settings
  1.3.4 Others
1.4 Development History of Blood Glucose Device
1.5 Market Status and Trend of Blood Glucose Device 2013-2023
  1.5.1 Global Blood Glucose Device Market Status and Trend 2013-2023
  1.5.2 Regional Blood Glucose Device Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Blood Glucose Device 2013-2017
2.2 Production Market of Blood Glucose Device by Regions
  2.2.1 Production Volume of Blood Glucose Device by Regions
  2.2.2 Production Value of Blood Glucose Device by Regions
2.3 Demand Market of Blood Glucose Device by Regions
2.4 Production and Demand Status of Blood Glucose Device by Regions
  2.4.1 Production and Demand Status of Blood Glucose Device by Regions 2013-2017
  2.4.2 Import and Export Status of Blood Glucose Device by Regions 2013-2017

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Production Volume of Blood Glucose Device by Types
3.2 Production Value of Blood Glucose Device by Types
3.3 Market Forecast of Blood Glucose Device by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Blood Glucose Device by Downstream Industry
4.2 Market Forecast of Blood Glucose Device by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BLOOD GLUCOSE DEVICE

5.1 Global Economy Situation and Trend Overview
5.2 Blood Glucose Device Downstream Industry Situation and Trend Overview

CHAPTER 6 BLOOD GLUCOSE DEVICE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

6.1 Production Volume of Blood Glucose Device by Major Manufacturers
6.2 Production Value of Blood Glucose Device by Major Manufacturers
6.3 Basic Information of Blood Glucose Device by Major Manufacturers
  6.3.1 Headquarters Location and Established Time of Blood Glucose Device Major Manufacturer
  6.3.2 Employees and Revenue Level of Blood Glucose Device Major Manufacturer
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 BLOOD GLUCOSE DEVICE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Abbott Laboratories (U.S.)
  7.1.1 Company profile
  7.1.2 Representative Blood Glucose Device Product
  7.1.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Abbott Laboratories (U.S.)
7.2 ARKRAY (Japan)
  7.2.1 Company profile
  7.2.2 Representative Blood Glucose Device Product
  7.2.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of ARKRAY (Japan)
7.3 Dexcom (U.S.)
  7.3.1 Company profile
  7.3.2 Representative Blood Glucose Device Product
  7.3.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Dexcom (U.S.)
7.4 F.Hoffmann-La Roche Ltd (Switzerland)
  7.4.1 Company profile
  7.4.2 Representative Blood Glucose Device Product
  7.4.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche Ltd (Switzerland)
7.5 Johnson & Johnson (U.S.)
  7.5.1 Company profile
  7.5.2 Representative Blood Glucose Device Product
  7.5.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Johnson & Johnson (U.S.)
7.6 Medtronic (U.S.)
  7.6.1 Company profile
  7.6.2 Representative Blood Glucose Device Product
  7.6.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Medtronic (U.S.)
7.7 Nipro Diagnostics (U.S.)
  7.7.1 Company profile
  7.7.2 Representative Blood Glucose Device Product
  7.7.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Nipro Diagnostics (U.S.)
7.8 Terumo Medical Corporation (U.S.)
  7.8.1 Company profile
  7.8.2 Representative Blood Glucose Device Product
  7.8.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Terumo Medical Corporation (U.S.)

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BLOOD GLUCOSE DEVICE

8.1 Industry Chain of Blood Glucose Device
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BLOOD GLUCOSE DEVICE

9.1 Cost Structure Analysis of Blood Glucose Device
9.2 Raw Materials Cost Analysis of Blood Glucose Device
9.3 Labor Cost Analysis of Blood Glucose Device
9.4 Manufacturing Expenses Analysis of Blood Glucose Device

CHAPTER 10 MARKETING STATUS ANALYSIS OF BLOOD GLUCOSE DEVICE

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications